The Effect of Selective D- or Nα-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20

In vivo pharmacokinetics studies have shown that the proline-rich antimicrobial peptide, A3-APO, which is a discontinuous dimer of the peptide, Chex1-Arg20, undergoes degradation to small fragments at positions Pro6-Arg7 and Val19-Arg20. With the aim of minimizing or abolishing this degradation, a series of Chex1-Arg20 analogs were prepared via Fmoc/tBu solid phase peptide synthesis with D-arginine or, in some cases, peptide backbone Nα-methylated arginine, substitution at these sites. All the peptides were tested for antibacterial activity against the Gram-negative bacterium Klebsiella pneumoniae. The resulting activity of position-7 substitution of Chex1-Arg20 analogs showed that arginine-7 is a crucial residue for maintaining activity against K. pneumoniae. However, arginine-20 substitution had a much less deleterious effect on the antibacterial activity of the peptide. Moreover, none of these peptides displayed any cytotoxicity to HEK and H-4-II-E mammalian cells. These results will aid the development of more effective and stable PrAMPs via judicious amino acid substitutions.

[1]  L. Otvos,et al.  Membrane interactions of proline-rich antimicrobial peptide, Chex1-Arg20, multimers. , 2016, Biochimica et biophysica acta.

[2]  R. Hoffmann,et al.  Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates. , 2005, Journal of medicinal chemistry.

[3]  L. Otvos,et al.  The antibacterial effect of a proline-rich antibacterial peptide A3-APO. , 2009, Current medicinal chemistry.

[4]  K. Lee,et al.  Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. , 1999, Biochemical pharmacology.

[5]  R. Hoffmann,et al.  Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens. , 2012, ACS chemical biology.

[6]  Daniel N. Wilson,et al.  The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex , 2015, Nature Structural &Molecular Biology.

[7]  L. Otvos,et al.  Alternative stabilities of a proline‐rich antibacterial peptide in vitro and in vivo , 2008, Protein science : a publication of the Protein Society.

[8]  L. Otvos,et al.  C-Terminal Modification and Multimerization Increase the Efficacy of a Proline-Rich Antimicrobial Peptide. , 2017, Chemistry.

[9]  R. Hoffmann,et al.  Ribosomal binding and antibacterial activity of ethylene glycol‐bridged apidaecin Api137 and oncocin Onc112 conjugates , 2016, Journal of peptide science : an official publication of the European Peptide Society.

[10]  A. Schmidtchen,et al.  Role of Aromatic Amino Acids in Lipopolysaccharide and Membrane Interactions of Antimicrobial Peptides for Use in Plant Disease Control* , 2016, The Journal of Biological Chemistry.

[11]  P. Christen,et al.  The Proline-rich Antibacterial Peptide Bac7 Binds to and Inhibits in vitro the Molecular Chaperone DnaK , 2009, International Journal of Peptide Research and Therapeutics.

[12]  L. Otvos,et al.  Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria , 2014, Amino Acids.

[13]  A. Ramamoorthy,et al.  Antimicrobial Peptides: Insights into Membrane Permeabilization, Lipopolysaccharide Fragmentation and Application in Plant Disease Control , 2015, Scientific Reports.

[14]  Daniel N. Wilson,et al.  Structure of the mammalian antimicrobial peptide Bac7(1–16) bound within the exit tunnel of a bacterial ribosome , 2016, Nucleic acids research.

[15]  P. Schaaf,et al.  Antibacterial Peptide-Based Gel for Prevention of Medical Implanted-Device Infection , 2015, PloS one.

[16]  M. Benincasa,et al.  Effect of size and N-terminal residue characteristics on bacterial cell penetration and antibacterial activity of the proline-rich peptide Bac7. , 2015, Journal of medicinal chemistry.

[17]  Raktim N. Roy,et al.  The Mechanism of Inhibition of Protein Synthesis by the Proline-Rich Peptide Oncocin , 2015, Nature Structural &Molecular Biology.

[18]  R. Hancock,et al.  Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. , 2013, Nature chemical biology.

[19]  L. Otvos,et al.  Multimerization of a Proline-Rich Antimicrobial Peptide, Chex-Arg20, Alters Its Mechanism of Interaction with the Escherichia coli Membrane. , 2015, Chemistry & biology.

[20]  A. Liguori,et al.  N-Methylated α-Amino Acids And Peptides: Synthesis And Biological Activity. , 2016, Mini reviews in medicinal chemistry.

[21]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[22]  L. Otvos,et al.  Current challenges in peptide-based drug discovery , 2014, Front. Chem..

[23]  I. Kovalszky,et al.  Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice , 2015, Amino Acids.

[24]  G. Qiao,et al.  Combating multidrug-resistant Gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers , 2016, Nature Microbiology.

[25]  H. Goossens,et al.  Antibiotic resistance—the need for global solutions , 2013, BDJ.

[26]  R. Hoffmann,et al.  Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. , 2014, Angewandte Chemie.

[27]  L. Otvos,et al.  Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved. , 2011, International journal of antimicrobial agents.

[28]  L. Otvos,et al.  C-Terminal Modifications Broaden Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20 , 2015 .

[29]  S. Lovas,et al.  The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. , 2001, Biochemistry.